Delayed internalization and lack of recycling in a beta2-adrenergic receptor fused to the G protein alpha-subunit by Di Certo, Maria Grazia et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Delayed internalization and lack of recycling in a beta2-adrenergic 
receptor fused to the G protein alpha-subunit
Maria Grazia Di Certo*1, Enrico M Batassa2,3, Ida Casella4, 
Annalucia Serafino5, Aristide Floridi6,7, Claudio Passananti8,9, 
Paola Molinari†4 and Elisabetta Mattei†1,9
Address: 1Istituto di Neurobiologia e Medicina Molecolare, CNR, c/o Fondazione Santa Lucia/EBRI, Via del Fosso di Fiorano 64/65, 00143 Rome, 
Italy, 2Dipartimento di Biotecnologie Cellulari ed Ematologia, Sezione di Genetica Molecolare, Università di Roma "La Sapienza", Viale Regina 
Elena, 324 00161 Rome, Italy, 3EBRI-European Brain Research Institute, Via del Fosso di Fiorano, 64/65, 00143 Rome, Italy, 4Dipartimento del 
Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy, 5Istituto di Neurobiologia e Medicina Molecolare, CNR, Tor 
Vergata, Via del Fosso del Cavaliere, 100 00133 Rome, Italy, 6Dipartimento di Medicina Sperimentale, Via Vetoio, Coppito 2, Università de 
L'Aquila, 67100 L'Aquila, Italy, 7Laboratory "B", Regina Elena Cancer Institute, Via delle Messi d'Oro, 156 00158 Rome, Italy, 8Istituto di Biologia 
e Patologia Molecolari, CNR, c/o Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy and 9AIRC-Rome Oncogenomic 
Center (ROC), Via delle Messi d'Oro, 156 00158 Rome, Italy
Email: Maria Grazia Di Certo* - mariagrazia.dicerto@inmm.cnr.it; Enrico M Batassa - e.batassa@ebri.it; Ida Casella - ida.casella@iss.it; 
Annalucia Serafino - annalucia.serafino@artov.inmm.cnr.it; Aristide Floridi - floridi@univaq.it; Claudio Passananti - passananti@ifo.it; 
Paola Molinari - paola.molinari@iss.it; Elisabetta Mattei - elisabetta.mattei@inmm.cnr.it
* Corresponding author    †Equal contributors
Abstract
Background: Chimeric proteins obtained by the fusion of a G protein-coupled receptor (GPCR) sequence to the N-
terminus of the G protein α-subunit have been extensively used to investigate several aspects of GPCR signalling.
Although both the receptor and the G protein generally maintain a fully functional state in such polypeptides, original
observations made using a chimera between the β2-adrenergic receptor (β2AR) and Gαs indicated that the fusion to the
α-subunit resulted in a marked reduction of receptor desensitization and down-regulation. To further investigate this
phenomenon, we have compared the rates of internalization and recycling between wild-type and Gαs-fused β2AR.
Results: The rate of agonist-induced internalization, measured as the disappearance of cell surface immunofluorescence
in HEK293 cells permanently expressing N-terminus tagged receptors, was reduced three-fold by receptor-G protein
fusion. However, both fused and non-fused receptors translocated to the same endocytic compartment, as determined
by dual-label confocal analysis of cells co-expressing both proteins and transferrin co-localization.
Receptor recycling, determined as the reversion of surface immunofluorescence following the addition of antagonist to
cells that were previously exposed to agonist, markedly differed between wild-type and fused receptors. While most of
the internalized β2AR returned rapidly to the plasma membrane, β2AR-Gαs did not recycle, and the observed slow
recovery for the fusion protein immunofluorescence was entirely accounted for by protein synthesis.
Conclusion: The covalent linkage between β2AR and Gαs does not appear to alter the initial endocytic translocation of
the two proteins, although there is reduced efficiency. It does, however, completely disrupt the process of receptor and
G protein recycling. We conclude that the physical separation between receptor and Gα is not necessary for the transit
to early endosomes, but is an essential requirement for the correct post-endocytic sorting and recycling of the two
proteins.
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Background
The activity of G protein-coupled receptors (GPCRs) is
regulated by a sophisticated balance between molecular
mechanisms governing receptor signalling, desensitiza-
tion and resensitization. An important role in the regula-
tion of GPCRs functions is played by the agonist-
mediated internalization of receptors into intracellular
compartments from which they may be sorted into spe-
cific endosomal pathways [reviewed in ref. [1-3]]. Thus,
the characterization of the molecular events involved in
the regulation of the intracellular trafficking of receptors is
a fundamental question in cell biology.
Over the past several years, the agonist-promoted inter-
nalization of β2-adrenergic receptor (β2AR), a prototypic
member of the GPCR superfamily, has become the subject
of intensive studies. Several investigations established
that, in response to agonist stimulation, β2ARs undergo
rapid phosphorylation by both second messenger-
dependent protein kinases and G protein-coupled recep-
tor kinases (GRKs) [3]. This event targets receptors for the
binding of arrestin proteins, which sterically uncouples
receptors from their cognate heterotrimeric G proteins
and favours the receptors endocytosis via clathrin-coated
vesicles into endosomal compartments [1,4,5]. As a con-
sequence of this, β2ARs are exposed to dephosphoryla-
tion, following which receptors are recycled back to the
plasma membrane surface as fully sensitized receptors [6].
Although many of the molecular mechanisms described
for β2AR might apply equally well to other GPCRs, the
diversity in receptor structures corresponds to important
differences in the intracellular trafficking patterns, as well
as to the functional signal transduction of distinct GPCR
subtypes. For example, regarding beta-subtypes of adren-
ergic receptors (β1, β2 and β3-AR), it is known that, unlike
β2AR, β3AR does not internalize in response to agonist;
likewise, human β1AR is more resistant to agonist-medi-
ated down-regulation and, although it uses the same
endocytosis mechanism as human β2AR, it is sorted to dif-
ferent endosomal compartments [7-9]. Other GPCRs that
internalize following agonist activation are targeted to lys-
osomes for degradation, or are retained within endosomal
compartments [10-12]. Moreover, relatively little is
known about the mechanisms that determine the specifi-
city of GPCR trafficking after endocytosis. It is established
that the sorting of internalized β2AR between recycling
and degradative endocytic pathways is controlled by a
protein interaction involving the distal carboxyl-terminal
cytoplasmic domain of the receptor. Mutations of this
sequence inhibit efficient recycling and cause the missort-
ing of internalized receptors to lysosomes, thereby
increasing the down-regulation [13].
Important advancements in the knowledge of intracellu-
lar trafficking of β2AR have been reached through studies
that used powerful tools, such as real-time optical-analy-
sis, to visualize the dynamics of receptor trafficking in liv-
ing cells. At first, the sub-cellular redistribution of
epitope-tagged β2AR in response to agonist activation was
observed by confocal fluorescence microscopy, and then
by direct visualization of β2AR-green fluorescent protein
(GFP) chimeras in cells transiently or stably expressing the
fusion protein [14-16]. Importantly, experiments employ-
ing this technical strategy have suggested that sequestered
β2ARs undergo processing through endosomal compart-
ments in a similar way to that observed for constitutively
internalized receptors, such as the transferrin receptor
[14]. After internalization, β2AR rapidly colocalizes with
transferrin into recycling endosomal vesicles, but follow-
ing prolonged exposure to agonist, it traffics through lys-
osomal vesicles as part of a down-regulation process [16].
Moreover, relevant information about GPCR endocytosis
emerged from studies that used GFP fusion proteins to
provide the opportunity not only to observe β2-adrenergic
receptor trafficking, but also to study the functional
dynamics of G proteins in real time. It was reported that,
using a Gαs-GFP construct, stimulation of COS-1 cells
with isoproterenol resulted in the movement of the Gαs-
GFP fusion protein from the plasma membrane to the
cytoplasm [17]. Moreover, Hynes et al. recently employed
strategies that allowed the simultaneous imaging of the α
and βγ components of heterotrimeric G proteins in live
cells. They showed that Gs and β2AR dissociate upon ago-
nist stimulation, internalize via different mechanisms and
traffic to distinct sub-cellular localizations [18]. To further
address this question, we report here a study on agonist-
mediated internalization and intracellular sorting
between the wild type adrenergic receptor, β2AR, com-
pared to that of the chimeric receptor, β2AR-Gαs, resulting
from the fusion of β2-adrenergic receptor with the amino-
terminal of the G protein α-subunit [19].
Although the β2AR-Gαs exhibits an unaffected ability to
transduce adrenergic signals and an increased sensitivity
to agonists as compared to wild type receptor, here we
show that the fusion of β2AR to Gαs slows down agonist-
induced internalization and strongly affects the recycling
of receptor to the plasma membrane, even if β2AR-Gαs is
targeted into endocytic compartments similar to those
observed for the non-fused receptor.
Results and discussion
MAPKs activation by β2AR-Gαs in HEK293 cells
GPCRs activate MAPKs by multiple converging mecha-
nisms [20,21]. To test the ability of the fusion protein
β2AR-Gαs to induce MAPK signalling, the agonist-medi-
ated activation of extra cellular signal-regulated kinases
(ERK1/2), also known as p42/44 MAPK, was analysed by
western blotting. HEK293 cells stably expressing theBMC Cell Biology 2008, 9:56 http://www.biomedcentral.com/1471-2121/9/56
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β2AR-Gαs (HEK293/β2AR-Gαs) or wild type β2-adrenergic
receptor (HEK293/β2AR) were treated for increasing times
with the agonist isoproterenol (1 μM), then cell extracts
were subjected to SDS-PAGE and blots were probed with
a monoclonal antibody specific for the phosphorylated
ERK1/2 proteins. As shown in figure 1, the isoproterenol
stimulation of HEK293/β2AR-Gαs resulted in both ERK-2
(major band at 42 kDa) and ERK-1 (minor band at 44
kDa) phosphorylation, whose activities were enhanced
following 10 min of agonist treatment and then rapidly
declined without other activation peaks within 4 hours. A
similar time-course of ERK activation was observed in the
cells stably expressing the wild type receptor.
In agreement with previous findings, this result confirms
that the fusion of the G protein α-subunit to β2AR does
not alter the functional properties of the receptor, which
retains its ability to activate cellular signalling.
β2AR-Gαs and β2AR show different internalization kinetics 
following agonist stimulation
The exposure of cell surface β2ARs to agonist results in a
time-dependent internalization of receptors. Internaliza-
tion properties of the β2AR-Gαs fusion protein were inves-
tigated using both qualitative and quantitative
experimental strategies. Immunofluorescence experi-
ments were performed on HEK293 cells stably expressing
the Flag-tagged chimeric (HEK293/β2AR-Gαs) or wild
type (HEK293/β2AR) receptors following visualization
with an epifluorescence microscope. Figure 2A shows a
typical experiment in which the cells were treated with 1
μM isoproterenol for the indicated times, fixed in formal-
dehyde and subjected to indirect immunofluorescence
using an anti-Flag antibody, as described in the Methods
section. As shown in figure 2A, the wild type receptor rap-
idly disappeared from the plasma membrane within 5
minutes of agonist treatment. The same amount of time
was not sufficient to induce a significant internalization of
the chimeric receptor, as indicated by the high immuno-
reactivity to Flag-antibody retained on the plasma mem-
brane of cells expressing the fusion protein. An
appreciable decrease in the surface levels of the fusion
protein started at 20 minutes, but the extensive loss of
plasma membrane β2AR-Gαs was only observed after 60
minutes of agonist stimulation. At this time, indeed, the
permeabilization of samples with a non-anionic deter-
gent, performed before the immuno-staining procedure,
allowed for the observation of an intracellular redistribu-
tion of the wild type as well as the chimeric receptor (fig.
2B). To quantify the internalization rates of the chimeric
and wild type proteins, we performed a fluorimetric assay.
HEK293 cells stably expressing β2AR-Gαs or native recep-
Agonist-mediated activation of endogenous MAP kinases Figure 1
Agonist-mediated activation of endogenous MAP kinases. Agonist-mediated activation of MAP kinases (ERK1/2) was 
detected by immunoblotting performed on stably transfected cells expressing the fusion protein (HEK293/β2AR-Gαs) or the 
wild type β2-adrenergic receptor (HEK293/β2AR). Cells were first incubated in the absence (0) or presence of 1 μM isoproter-
enol (ISO) for the indicated times, and then whole-cell extracts were subjected to SDS-PAGE. The immunoreactivity of the 
endogenous ERK1/2 following agonist-induced phosphorylation was detected by probing blots with Phospho-p44/42 MAP 
kinases rabbit monoclonal antibody. Samples were normalized for protein content by reprobing blots with a monoclonal anti-
body to alpha-tubulin.
HEK293/ 2 AR HEK293/ 2 AR-G s
phospho ERK 1/2
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tor were seeded onto multiwell plates and treated with 1
μM isoproterenol for the indicated times (fig. 2C). After
fixation, the surface receptors were immuno-stained with
an anti-Flag antibody and labelled with Alexa Fluor 488-
conjugated anti mouse IgG. The fluorescence measured by
a multi-label counter clearly indicates that the chimeric
protein has a lower rate of internalization than the wild
type receptor. The computed t1/2 was 12 and 33 min for
β2AR and β2AR-Gαs, respectively.
Inefficient recycling of internalized β2AR-Gαs
To investigate whether the fusion of β2AR to G protein α-
subunit also affects the recycling processes of the receptor,
we used the same technical approach used for the inter-
nalization studies. First, HEK293/β2AR or HEK293/β2AR-
Gαs cells were exposed to 1 μM isoproterenol for 5 hours
to induce the maximal agonist-mediated internalization,
as shown in figure 2C. Then we added the antagonist pro-
pranolol and incubated the cells for an additional hour, to
allow the cell surface recovery of the receptors. Finally, an
Agonist-dependent internalization of β2AR-Gαs Figure 2
Agonist-dependent internalization of β2AR-Gαs. A. HEK293 cells stably expressing β2AR or β2AR-Gαs were not treated 
(NT) or treated with isoproterenol for 5, 20 or 60 minutes to induce receptor internalization. The cells were then fixed in 4% 
formaldehyde and sequentially immuno-stained with anti-Flag and Alexa-Fluor 594 conjugated anti-mouse IgG. The disappear-
ance of the fluorescence from the plasma membrane was monitored with an epifluorescence microscope. Scale bars, 20 μm. B. 
Immunofluorescence showing the recruitment of both receptors into endocytic vesicles after 60 minutes of agonist treatment. 
In this case, cells were permeabilized with 0.2% NP-40 before the immunofluorescence reaction. Nuclei were stained with 
Hoechst 33258 (1 μg/ml). Scale bars, 10 μm. C. β2AR-Gαsand wild type β2AR expressing cells were cultured on 96 multiwell 
plates and treated with isoproterenol for the indicated times (abscissae). Fixed cells were immuno-stained with Flag-antibody 
followed by Alexa-Fluor 488-conjugated anti-mouse IgG. Nuclei were stained with Hoechst 33258 (1 μg/ml). Fluorescence was 
measured by a multi-label counter. Each point represents the mean of 4 different experiments performed in triplicate. Data are 
expressed as ratios of the relative fluorescence measured after immuno-staining with the Alexa-Fluor 488-labeled secondary 
antibody (RFUFitc) and following Hoechst staining of the same monolayers (RFUHoechst), as described in Methods. Data were 
fitted to an exponential decay equation of the form: y = a1 exp (-k t) + a0, where t is time in min, a1 and a0 are decaying and not 
decaying components of fluorescence, respectively, and k, the time constant, represents the inverse of the half-time (t1/2) of the 
disappearance of immunoreactivity from the cell surface.
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immunofluorescence assay was performed to visualize the
recycling of epitope-tagged receptors via fluorescence
microscopy (fig. 3A). Flag-epitopes immuno-staining
revealed that, after 5 hours of incubation with isoprotere-
nol, both receptors disappeared from the cell surface (fig.
3A panels b,b'). However, following an additional hour of
incubation with the antagonist propranolol, native β2 AR
was almost completely returned to the cell surface, in
sharp contrast with the β2AR-Gαs protein, which showed
only a slight plasma membrane redistribution (fig. 3A
panels c,c'). The inability of the chimeric receptor to recy-
cle back to the plasma membrane was also confirmed by
a fluorimetric assay performed to estimate the cell surface
recovery of receptors upon antagonist incubation (fig.
3B). HEK293/β2AR or HEK293/β2AR-Gαs cells were cul-
tured on 96 multiwell plates and exposed to isoproterenol
(1 μM) for 5 hours. The agonist-mediated recruitment of
receptors to intracellular compartments was stopped by
the addition of propranolol (1 μM) for increasing times,
after which an immunofluorescence assay was performed
to visualize the surface receptors (fig. 3B). At each time
point, the cell surface recovery of either epitope-tagged β2
AR or β2AR-Gαs was evaluated by the measurement of cell
surface fluorescence by a multi-label counter. As shown in
figure 3B, upon addition of the antagonist, the wild type
receptor rapidly relocalized to the plasma membrane, in a
time-dependent fashion. Approximately 50% of internal-
ized β2AR returned to the plasma membrane within 15
minutes, thus showing a fast component of recycling.
Over this time, the further exposure of cells to antagonist
favoured a nearly complete recycling of β2AR by a slow
component. As expected, the difference in the recycling
rates between fused and non-fused receptors was dra-
matic. In fact, the fluorimetric measurement performed
on cells expressing the β2AR-Gαs resulted in a slow as well
as modest relocalization of receptors to the plasma mem-
brane, and no significant recycling of the fusion protein
was observed until after 60 minutes of antagonist treat-
ment. Moreover, to exclude the membrane exposure of
newly synthesized receptors from analysis, we also per-
formed the same experiments in the presence of cyclohex-
imide (CHX), a protein synthesis inhibitor. Under this
condition, we observed that the recovery of the wild type
receptor occurred by both recycling (fast component) and
resynthesis (slow component). In contrast, the recovery of
the fused receptor occurred only by new synthesis.
β2AR-Gαs and β2AR co-localization with endocytosed 
transferrin
In order to investigate the failure of the chimeric receptor
to recycle back to the plasma membrane in more detail,
we compared the agonist-mediated sub-cellular localiza-
tion of β2AR and β2AR-Gαs receptors with that of endocy-
tosed transferrin, a well-established marker of early and
rapid recycling endosomes [14,22,23]. The extent of co-
localization between endocytosed transferrin and either
native or chimeric receptors was examined by dual-label
confocal microscopy (fig. 4A). As indicated by the yellow
spots in the merged panel of figure 4A, most of the wild
type β2AR co-localized with the tracer transferrin, consist-
ent with the typical rapid recycling of the β2AR, whereas
β2AR-Gα trafficked through transferrin-positive endo-
somal compartments, with an apparent lower grade com-
pared to the wild type receptor. The fraction of vesicles
showing transferrin-receptor co-localization was approxi-
mately 43% and 37% for the wild type and chimeric
receptors, respectively (fig. 4B). This slight difference
could be explained by the different kinetics of internaliza-
tion displayed by the two receptors (fig. 2). As the above
experiment demonstrated, 30 minutes corresponds to the
agonist-exposure time at which β2 AR, but not β2AR-Gαs
receptor, shows maximal agonist-mediated internaliza-
tion. Thus, the resistance to agonist-induced endocytosis
showed by the fusion protein could also result in a differ-
ent kinetic rate of transfer into and out of specific vesicles,
without, however, changing its endosomal targeting.
Taken together, these data support the hypothesis that the
failure of β2AR-Gαs to undergo recycling is not linked to it
sorting into endosomal compartments distinct from those
that efficiently translate their cargo to the plasma mem-
brane.
β2AR-Gαs and wild type receptor are targeted to the same 
endocytic vesicles
The experiments reported above do not exclude the possi-
bility that, following agonist-mediated internalization,
β2AR-Gαs and wild type β2AR may traffic through similar
endosomal compartments. To better understand this, we
carried out experiments in which the endocytic trafficking
of β2-adrenergic receptors was analyzed in a co-expression
system using a different tagged version of the native recep-
tor.
HEK293/β2AR-Gαs cells were transiently transfected with
an amino-terminus HA-tagged β2AR (HA-β2AR), were
incubated with or without 1 μM isoproterenol for 5 hours
to induce maximal internalization without affecting the
recycling of the native receptor, were fixed, and were then
subjected to confocal microscopy. In the absence of ago-
nist stimulation, the immunoreactivity of Flag-β2AR-Gαs,
as well as that HA-β2AR, was typically localized at the
plasma membrane. In response to agonist, each receptor
redistributed from the cell surface to a population of cyto-
plasmic vesicles that resulted in complete overlapping in
the merged colour images (fig. 5). These results, in addi-
tion to the transferrin co-localization experiments, con-
firm that the fusion of the G protein α-subunit to the wild
type β2AR does not target the chimeric receptor to endo-
somal compartments distinct from those observed for the
wild type protein. Next, using the same experimental strat-BMC Cell Biology 2008, 9:56 http://www.biomedcentral.com/1471-2121/9/56
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Figure 3
Antagonist-mediated recycling of internalized β2AR andβ2AR-Gαs. A. Cells stably expressing the β2AR or the fusion 
protein β2AR-Gαs were treated (panels b, b', c, c') or not (panels a, a') with the agonist isoproterenol to induce complete 
receptor internalization. The agonist-mediated endocytosis was stopped by the addition of the antagonist propranolol for 60 
minutes (panels c,c'). Fixed cells were then processed by fluorescence microscopy for membrane immuno-localization of Flag-
tagged receptors, as described in Methods. Scale bars, 20 μm. B. Cells expressing wild type or fusion protein receptor were 
incubated with 1 μM isoproterenol for 5 hours to induce maximal internalization. Reversal of internalization was initiated by 
adding 1 μM propranolol, and cells were fixed and subjected to immuno-staining with Flag-antibody and Alexa Fluor 488-conju-
gated anti mouse IgG, at the indicated times, to detect the recovery of the cell surface receptors. Data (means of 3 experi-
ments) are reported as the percent of the control (not stimulated) receptor immunoreactivity. The same experiment was 
performed in the absence (control) or presence of cycloheximide (CHX).
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egy, we also examined whether or not the inability of the
chimeric receptor to recycle back was affected by the pres-
ence of the wild type receptor.
Analysis by epifluorescence microscopy of HEK293/β2AR-
Gαs cells transiently expressing the wild type β2AR, and
treated for five hours with 1 μM isoproterenol, confirmed
that both receptors were recruited into the same endocytic
vesicles (fig. 6). However, when the antagonist pro-
pranolol was added to stop receptor internalization, we
observed an almost complete recovery of the wild type
receptor on the cell surface, whereas the β2AR-Gαs was
entirely retained in the intracellular vesicles. Moreover, an
intracellular pool of both receptors continued to co-local-
ize, probably in correspondence of compartments that
drive them to a common degradative pathway.
Conclusion
In this study, we have investigated the effect of a C-termi-
nally tethered G protein α-subunit on the recycling rate
and post-endocytic fate of the β2AR receptor. We observed
β2AR-Gαs and β2AR co-localization with endocytosed transferrin Figure 4
β2AR-Gαs and β2AR co-localization with endocytosed transferrin. A. The cells were incubated for 30 min with 100 
μM Alexa-Fluor 488 conjugated transferrin, a marker of early and recycling endosomes, and with 1 μM isoproterenol for 
another 30 minutes. The samples were then washed, fixed and immuno-stained with antibody against Flag-epitopes, as 
described in Methods. The sub-cellular distribution and co-localization of both receptors with transferrin were revealed by con-
focal microscopy. The data are representative images from three independent experiments. Red, Flag-tagged receptor Alexa-
Fluor 594 stained; Green, Alexa-Fluor 488 conjugated transferrin. In the merged images, numerous yellow vesicular spots, corre-
sponding to the co-localization between internalized receptors and transferrin, are visualized. Scale bars, 10 μm. B. The graph 
indicates the fraction of endocytic vesicles in which internalized receptors co-localized with the Alexa-Fluor 488 conjugated 
transferrin. Error bars represents the S.D. of data collected from multiple fields (n = 6) from 4 independent experiments.
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two important differences between the fused and non-
fused receptors.
The first is a substantial reduction in the internalization
rate of the receptor-Gα fusion protein compared to the
native β2-adrenergic receptor (fig. 2). Therefore, depend-
ing on the extent to which intracellular recruitment in a
given cell contributes to the attenuation of receptor
responsiveness, these results suggest that β2AR-Gαs may
be less susceptible to desensitization. This also explains
previous reports indicating an increased resistance to
desensitization and an enhanced anti-proliferative effect
of isoproterenol in S49 cells transfected with this type of
fusion protein [24].
The reduced rate of internalization was apparently not
due to a divergent process of endocytosis, since β2AR-Gαs
was targeted to the same endosomal compartment where
the wild type receptor was translated (fig. 4, 5, 6). This
might reflect a reduced ability of the fused receptor to
interact with G protein receptor kinases (GRKs), since
receptor-Gα fusion proteins were found less capable of
interacting with Gβγ subunits, which play a crucial role in
recruiting GRKs to the receptor [19]. A detailed study on
the ability of β2AR-Gαs to undergo GRK-mediated phos-
phorylation and β-arrestin docking will obviously be nec-
essary to address such questions.
The second and more remarkable difference between Gα-
fused and non-fused receptor is the total inability of β2AR-
Gα to undergo recycling, which makes endocytosis an
Dual-localization of co-expressed β2-adrenergic receptors by confocal microscopy Figure 5
Dual-localization of co-expressed β2-adrenergic receptors by confocal microscopy. HEK293 cells stably expressing 
Flag-tagged β2AR-Gαs receptor were transiently transfected with a HA-tagged β2AR construct to obtain the co-expression of 
the two receptors in the same cell. Cells were treated (Agonist) or not (Control) with 1 μM isoproterenol for 5 hours, fixed 
and subjected to indirect immunofluorescence analysis as described in Methods, and then visualized by confocal microscopy. 
Co-localization of HA-β2AR (Alexa-Fluor 488 staining; green) with Flag-β2AR-Gαs (Alexa-Fluor 594 staining; red) is shown in 
the merged colour image by yellow staining. Photographs represent a typical situation observed in 4 independent experiments. 
Scale bars, 10 μm.
Control Agonist
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essentially irreversible process for the fusion protein. In
fact, the fast CHX-insensitive component of receptor
recovery to the cell surface was absent in cell expressing
the fused receptor and no recovery of fusion protein was
observed in cells treated with CHX (fig. 3), suggesting that
fusion proteins coming slowly back to the membrane
after internalization are only those derived from de novo
protein synthesis (fig. 3). Direct labelling in pulse-chase
experiments will be necessary to verify such possibility.
Moreover, multiplexed immunofluorescence staining of
differentially tagged fused and wild type receptors co-
transfected in the same cell clearly showed that, unlike
native receptors, the fused protein is selectively retained in
an intracellular compartment following the reversal of
internalization (fig. 6).
It is known that, upon agonist activation, β2-adrenergic
receptor and the Gα-subunit dissociate and leave the
plasma membrane to traffic through distinct endosomal
compartments, both of which result in recycling [18].
Moreover, unlike β2 AR, Gαs does not colocalize with
internalized transferrin, indicating that it does not traffic
into common recycling endosomes [25].
Dual-localization of co-expressed β2-adrenergic receptors after antagonist-mediated recycling Figure 6
Dual-localization of co-expressed β2-adrenergic receptors after antagonist-mediated recycling. HEK293 cells sta-
bly expressing Flag-β2AR-Gαs receptor were transiently transfected with HA-β2AR construct. After 48 hours, receptor inter-
nalization was induced by incubating cells with 1 μM isoproterenol for 5 hours. 1 μM propranolol was added (Agonist + 
Antagonist) or not (Agonist) for a further 60 minutes to stop receptor endocytosis. Fixed and immuno-stained cells were sub-
jected to epifluorescence microscopy, as described in Methods, to visualize the sub-cellular localization of HA-β2AR (Alexa-
Fluor 594 staining; red) and Flag-β2AR-Gαs (Alexa-Fluor 488 staining; green). Scale bars, 10 μm. Note that the antagonist allows 
the membrane return of the wild type receptor but not of the chimeric protein. Photographs represent the typical situation 
observed in 4 independent experiments.
Agonist Agonist + Antagonist
HA-E2 AR
Flag-E2 -GDs
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Thus, it is reasonable to suppose that, in the β2AR-Gα con-
struct, the receptor sequence played a critical role in dic-
tating the intracellular trafficking of the fusion protein in
response to agonist. On the other hand, the undissociable
covalent bond that ties together the two sequences
appears to be a sufficient modification to block the natu-
ral recycling mechanisms of both proteins. While more
investigations will be necessary to identify the exact nature
of the endocytic vesicles that irreversibly trap the fusion
protein inside the cell, our study allows us to pinpoint
which step of receptor endocytosis is most crucially
dependent on the physical separation of receptor from
Gα. The lack of dissociation, in fact, can reduce the effi-
ciency but does not prevent the initial phase of receptor
endocytosis. It does however disrupt the post-endocytic
fate of both receptor and Gα subunit.
Methods
Materials
Materials came from the following sources: cell culture
media, fetal bovine serum, G418 and Lipofectamine were
from Invitrogen. Isoproterenol, propranolol, anti-FLAG
monoclonal antibody (M1 clone), anti-HA polyclonal
antibody and Hoechst 33258 were from Sigma. Phospho-
p44/42 MAPK rabbit monoclonal antibody was from Cell
Signalling Technology. Alexa-Fluor 488-conjugated trans-
ferrin, and antibodies Alexa-Fluor 488 and Alexa-Fluor
594 goat anti-mouse IgG, were from Molecular Probes.
Nitrocellulose transfer membrane was from Sch-
leicher&Schuell. Enhanced chemiluminescent substrate
(ECL) for detection of HRP was from PIERCE.
Plasmids
The construction of full-length cDNA encoding the Flag-
tagged β2AR-Gαs fusion protein was described previously
[19].
The amino terminal Flag tagged wild receptor was
obtained in a similar way. Briefly, the cleavable prolactin
signal peptide tethered to the Flag epitope (DYKDDDDK)
was added immediately before the Gly2 in β2 AR by PCR-
based strategies and cloned in a pcDNA3 vector (Invitro-
gen).
The cDNA encoding for 3HA-β2AR was obtained by the
annealing of two synthetic oligonucleotides containing
the sequences of three sequential modules of the influ-
enza hemagglutinin HA epitope (AYPYDVPDYA), and
was cloned into pcDNA3 vector. Then, by PCR, we
obtained the cDNA encoding for the β2AR deprived of the
Met initiator codon, which was subcloned into the vector,
in frame with the 3 × HA epitope.
Cell Culture and Transfection
Human embryonic kidney (HEK293) cells stably express-
ing the wild type β2AR or chimeric protein β2AR-Gαs were
generated as described previously [19]. The total number
of expressed receptors was measured in membranes pre-
pared from the transfected cells using radioligand binding
assays, as described previously [19]. The levels of receptor
expression were 15 and 10.8 pmol/mg in cells expressing
wild type β2AR and β2AR-Gαs, respectively.
Cells were grown in Dulbecco's modified Eagle's medium
(DMEM; GIBCO) supplemented with 10% (v/v) fetal
bovine serum (FBS; GIBCO), 100 units/ml penicillin, 100
μg/ml streptomycin sulphate, and 200 μg/ml G418
(GIBCO) in a humidified atmosphere of 5% CO2 at 37°C.
For transient transfections, cells cultured in 35-mm tissue
culture dishes were transfected with 0.3 μg of pcDNA3/
HA-β2AR and 0.7 μg of empty vector using Lipofectamine
(Invitrogen), according to the manufacturer's instruc-
tions. The cells were allowed to express the transfected
gene for 48 hrs before harvesting.
Immunofluorescence
Cells were grown on 35-mm tissue culture dishes and fol-
lowing the various treatments were fixed with 4% buff-
ered formaldehyde for 20 minutes. If necessary, fixed cells
were permeabilized with 0.2% Nonidet P-40 (NP-40) in
phosphate-buffered saline (PBS) for 10 min to assure the
accessibility of intracellular and intravesicular antigens.
For the detection of epitope-tagged receptors, anti-Flag
mouse monoclonal antibody was added in blocking
buffer (1% BSA) for 50 min at room temperature (r.t.) fol-
lowed by Alexa-Fluor 594 conjugated anti-mouse IgG
(Molecular Probes). In dual staining experiments, co-
localization of Flag-tagged receptors and HA-tagged recep-
tors in a single cell line, was performed by incubating cells
with anti-Flag and anti-HA rabbit polyclonal antibody
(Sigma).
Stained specimens were examined by conventional epiflu-
orescence microscope (Olympus BX51; Tokyo, Japan) or
confocal microscope.
Confocal Laser Scanning Microscopy
Fluorescently labelled preparations were also observed by
a confocal fluorescent imaging system using the confocal
laser scanning microscope LEICA TCS 4D (Leach Instru-
ments, Heidelberg, Germany) supplemented with an
Argon/Kripton laser and equipped with 40 × 1.00–0.5 and
100 × 1.3–0.6 oil immersion lenses. The excitation/emis-
sion wavelengths employed were 488 nm/510 nm, and
568 nm/590 nm for specific Alexa-Fluor labelling. Confo-
cal sections were acquired at intervals of 0.5 μm from the
middle to the bottom toward the cells, and a 3D recon-BMC Cell Biology 2008, 9:56 http://www.biomedcentral.com/1471-2121/9/56
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struction image of the fluorescent signal was obtained. In
double staining experiments, confocal sections for both
fluorescent signals were taken simultaneously, the 3D
reconstruction images were recorded, and merged images
of the two signals were obtained using confocal micro-
scope software.
Receptor Internalization Assays
Cells, cultured on 96 multiwell plates (Nunc) until they
reached confluence, were stimulated with 1 μM isoproter-
enol (Sigma) at 37°C for different times to drive agonist-
induced internalization. At the end of the time-course,
cells were immediately fixed with 4% buffered formalde-
hyde for 20 min, incubated in blocking buffer for 30 min
and immuno-stained for 50 min with anti-FLAG mouse
monoclonal antibody (Sigma), followed by Alexa-Fluor
488 conjugated anti-mouse IgG (Molecular Probes).
Nuclei were stained with Hoechst 33258 (1 μg/ml). Fluo-
rescence was measured by a multi-label counter (Victor 2;
Wallac), setting excitation and emission filters as follows:
λex = 485/λem = 535, and λex = 355/λem = 460 for Alexa-
Fluor 488 and Hoechst, respectively. Each point was per-
formed in triplicate and the receptor internalization was
monitored in relationship to the decrease of fluorescence
from the plasma membrane.
Receptor Recycling Assays
For recycling studies, cells cultured on 96 multiwell plates
were incubated with 1 μM isoproterenol for 5 hrs to
induce maximal receptor internalization. Reversal of
internalization was initiated by adding the antagonist, 1
μM Propranolol (Sigma), for different times. In other
experiments, 50 μg/ml cycloheximide (CHX; Sigma) was
added during the last 2 hrs of agonist treatment. At the
end of the time-course, the cells were fixed and subjected
to immunofluorence followed by fluorimetry analysis as
above.
Receptor recycling from the endocytic pathway was esti-
mated by assaying the recovery of immunoreactive
epitopes at the cell surface that were accessible by mono-
clonal antibody.
Localization of Receptor with Endocytosed Transferrin
In order to estimate the degree of co-localization of the
receptor with endocytosed transferrin, cells were incu-
bated for 30 min at 37°C in culture medium containing
100 μM Alexa-Fluor 488-conjugated transferrin (Molecu-
lar Probes), and then 1 μM isoproterenol was added for an
additional 30 min.
Next, cells were washed twice in pre-warmed PBS to
remove non-internalized transferrin and were subjected
to immunofluorescence as above. Briefly, fixed cells were
permeabilized and immuno-stained for detection of Flag-
tagged receptors. Dual-label fluorescence microscopy was
performed as described above.
Immunoblotting for Phospho p42/44 MAP Kinases
Cells were first sensitized by incubating with the agonist
isoproterenol (1 μM) for different times and were then
dissolved in Laemmli's sample buffer. Samples were elec-
trophoresed through a 12% SDS-polyacrylamide gel
(SDS-PAGE) and transferred onto nitrocellulose mem-
branes (Schleicher&Schuell). Blots were incubated in
blocking buffer (5% w/v non fat dry-milk, 0,1% Tween-20
in Tris buffered saline) for 1 hrs at r.t., followed by incu-
bation overnight at 4°C with Phospho-p44/42 MAP
kinases rabbit monoclonal antibody (Cell Signalling
Technology), which detects endogenous levels of p42 and
p44 MAP kinases (ERK1/2) when phosphorylated at
Thr202 and Tyr204, respectively. Immunoreactive bands
probed with horseradish peroxidase-conjugated anti rab-
bit IgG antibody were visualized by chemiluminescence
(ECL; PIERCE), according to the manufacturer's instruc-
tions.
Samples were normalized for protein content by reprob-
ing blots with an alpha-tubulin monoclonal antibody
(Sigma).
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